Regulations.gov document
Male Breast Cancer: Developing Drugs for Treatment; Guidance for Industry; Draft Guidance
Other · FDA-2019-D-2966 · posted Aug 27, 2019
Key facts
| Document ID | FDA-2019-D-2966-0002 |
|---|---|
| Title | Male Breast Cancer: Developing Drugs for Treatment; Guidance for Industry; Draft Guidance |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2019-D-2966 |
| Posted | Aug 27, 2019 |
| Comment period opens | Aug 27, 2019 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: